NBCA DVT/PE Oncology Awareness Survey Methodology

NBCA’s DVT/PE Awareness Survey was conducted by the national survey firm USA/Direct, Inc. The oncology patient sample, screened from an online research panel, consisted of 500 adults diagnosed with cancer or recurrence of cancer within the prior 12 months (mean age 58 years; range 20-80+; 64% females), most of whom were receiving active treatment. Responses from patients who required a hospital stay for treatment (n=206) were compared to responses of patients who were exclusively treated as outpatients (n=294).

For more information, or to order free copies of the NBCA DVT/PE Awareness Survey DVD, contact NBCA at 877.4No.Clot (877-466-2568). NBCA is a patient-led advocacy organization dedicated to promoting patient and public awareness about the signs and symptoms of DVT and PE.

Prophylaxis Practices
DVT/PE Risk Versus THA/TKA Patient Awareness
Quick Facts
NBCA Survey Methodology

The NBCA DVT/PE Awareness Survey was made possible by a grant from Ortho-McNeil™, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. 

Current News

NBCA Designates a Michigan Hospital as First DVT Center of Excellence™ in the U.S.

NBCA is honored to announce MyMichigan Medical Center Midland as the first hospital in the U.S. to be designated a…

NBCA Designates Two AdventHealth Hospitals as Centers of Excellence™

The National Blood Clot Alliance (NBCA) is pleased to announce the designation of AdventHealth Palm Coast and AdventHealth Palm Coast…